Eunice S. Wang, MD | Authors

Articles

FLT3 Mutated AML: Are Triplets Better Than Doublets?

September 28, 2022

FLT3 tyrosine kinase inhibitor combination regimens may hold promise to not only improve outcomes for older individuals with FLT3-mutant but potentially for all patients , regardless of age or fitness.